Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Climb Global Solutions, Inc. (CLMB)
NASDAQInformation TechnologyTechnology DistributorsSnapshot 2026-11-04
$39.85-7.43%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologyTechnology DistributorsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.76 → 1.78 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CLMB yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Cash from operating activities improves to at least $16.8M in 2026-Q1 | Climb Global Solutions improves cash flow from operations to $16.8M in 2026-Q1. | Intact | cash from operating activities falls below $16.8M in 2026-Q1 | Cash from operations: $11.899M FY2026-Q3; GAAP. Published target: >=16.8 million USD. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 29, 202611,899,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a small-cap growth and acquisition-led business, rather than a low-risk compounder. The long-term thesis is intact: recent performance has strengthened, though execution and quarter-to-quarter risk remain important.
CLMB is described as cheap versus peers, and its valuation score has recently fallen. The expectations gap is negative, which suggests expectations may be demanding relative to the model, even though the pricing signal is tagged as justified and fragility is low.
Near-term results show strong momentum: Q3 sales rose 37%, and 19 of the top 20 vendors had sequential growth. Management is delivering on organic growth, while acquisition contributions and technology-investment outcomes remain unquantified. Near-term risk is considered quiet, but the small-cap profile and recent history of missed quarters warrant attention.
The multi-year view depends on sustaining organic growth and turning acquisitions, including the European platform expansion, into measurable results. Near term, a guidance cut would be a meaningful setback; easing rates or steadier results from sector peers could support the business backdrop.
For the next 1 to 3 years, CLMB combines improving business momentum and peer-relative cheapness with high execution risk and an expectations gap that remains a concern. The thesis is intact, but its strength hinges on continued growth and clear evidence that acquisitions and efficiency investments are working. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
EPS reaches at least $5.08 in FY26 |
| A primary condition in Climb Global Solutions, Inc.'s published investment case. The stated target is >=5.08 USD per share. |
| Intact |
| EPS falls below $5.08 in FY26 |
Diluted EPS: $0.43 per share FY2026-Q3; GAAP. Published target: >=5.08 USD per share. Annual target cannot be compared with a quarterly or TTM observation. Oct 29, 20260.43 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain gross profit near $26.5M in 2026-Q1 | A supporting condition in Climb Global Solutions, Inc.'s published investment case. The stated target is >=26.5 million USD. | Broken | gross profit falls below $26.5M in 2026-Q1 | Gross profit: $33.01M FY2026-Q3; GAAP. Published target: >=26.5 million USD. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 29, 202633,010,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Pursue M&A deals to drive growth and market presence | M&A activity supports growth and market presence expansion. | Intact | no meaningful M&A activity or growth from deals over next 12 months | 1 M&A deal closed vs active pursuit target CLMB signed a Sale and Purchase Agreement on Oct 21, 2026, to acquire 100% of NeoVAD shares. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.78 → $1.78 · observed estimates
$0.79B → $0.83B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.78 | $792,387,030 | 3 / 3 |
| 2026-07-25 | $1.78 | $792,387,030 | 3 / 3 |
| 2026-07-26 | $1.78 | $792,387,030 | 3 / 3 |
| 2026-07-27 | $1.77 | $796,390,275 | 2 / 2 |
| 2026-07-28 | $1.78 | $792,387,030 | 3 / 3 |
| 2026-07-29 | $1.78 | $792,387,030 | 3 / 3 |
| 2026-07-30 | $1.78 | $792,387,030 | 3 / 3 |
| 2026-07-31 | $1.77 | $796,390,275 | 2 / 2 |
| 2026-08-01 | $1.77 | $796,390,275 | 2 / 2 |
| 2026-08-02 | $1.78 | $792,387,030 | 3 / 3 |
| 2026-08-03 | $1.78 | $803,020,370 | 3 / 3 |
| 2026-08-04 | $1.78 | $803,020,370 | 3 / 3 |
| 2026-08-05 | $1.79 | $804,840,275 | 1 / 2 |
| 2026-08-06 | $1.79 | $804,840,275 | 1 / 2 |
| 2026-08-07 | $1.79 | $804,840,275 | 1 / 2 |
| 2026-08-08 | $1.75 | $802,353,700 | 3 / 3 |
| 2026-08-09 | $1.75 | $802,353,700 | 3 / 3 |
| 2026-08-10 | $1.75 | $802,353,700 | 3 / 3 |
| 2026-08-11 | $1.75 | $802,353,700 | 3 / 3 |
| 2026-08-12 | $1.79 | $804,840,275 | 1 / 2 |
| 2026-08-13 | $1.75 | $801,162,330 | 3 / 3 |
| 2026-08-14 | $1.79 | $804,840,275 | 1 / 2 |
| 2026-08-15 | $1.79 | $804,840,275 | 1 / 2 |
| 2026-08-16 | $1.79 | $804,840,275 | 1 / 2 |
| 2026-08-17 | $1.79 | $804,840,275 | 1 / 2 |
| 2026-08-18 | $1.79 | $804,840,275 | 1 / 2 |
| 2026-08-19 | $1.79 | $804,840,275 | 1 / 2 |
| 2026-08-20 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-21 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-22 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-23 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-24 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-25 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-26 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-27 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-28 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-29 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-30 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-08-31 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-01 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-02 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-03 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-04 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-05 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-06 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-07 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-08 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-09 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-10 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-11 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-12 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-13 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-14 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-15 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-16 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-17 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-18 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-19 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-20 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-21 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-22 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-23 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-24 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-25 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-26 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-27 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-28 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-29 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-09-30 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-01 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-02 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-03 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-04 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-05 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-06 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-07 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-08 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-09 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-10 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-11 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-12 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-13 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-14 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-15 | $1.76 | $803,446,700 | 2 / 2 |
| 2026-10-16 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-17 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-18 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-19 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-20 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-21 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-22 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-23 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-24 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-25 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-26 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-27 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-28 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-29 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-30 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-10-31 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-11-01 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-11-02 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-11-03 | $1.75 | $801,162,267 | 2 / 2 |
| 2026-11-04 | $1.78 | $832,216,033 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.